LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00066667
 53.77 84.90 930 6252 0.1487 0.4710
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 53.77 84.90 4700 6252 0.7517 0.9100
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 53.77 84.90 984 6252 0.1574 0.4844
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 53.77 84.90 4661 6252 0.7454 0.9075
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 55.48 84.90 1055 6567 0.1606 0.4943
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 55.48 84.90 4912 6567 0.7479 0.9095
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 55.48 84.90 1000 6567 0.1523 0.4816
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 55.48 84.90 4838 6567 0.7366 0.9049
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 57.18 84.90 1139 6963 0.1636 0.5044
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 57.18 84.90 5117 6963 0.7349 0.9054
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 57.18 84.90 1031 6963 0.1481 0.4810
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 57.18 84.90 5116 6963 0.7347 0.9053
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 58.88 84.90 1188 7291 0.1629 0.5079
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 58.88 84.90 5409 7291 0.7418 0.9091
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 58.88 84.90 1112 7291 0.1525 0.4925
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 58.88 84.90 5357 7291 0.7347 0.9063
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 60.59 84.90 1263 7641 0.1653 0.5157
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 60.59 84.90 5631 7641 0.7369 0.9081
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 60.59 84.90 1265 7641 0.1655 0.5160
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 60.59 84.90 5551 7641 0.7264 0.9039
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 62.29 84.90 1271 7934 0.1602 0.5119
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 62.29 84.90 5860 7934 0.7386 0.9095
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 62.29 84.90 1227 7934 0.1546 0.5038
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 62.29 84.90 5786 7934 0.7292 0.9058
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 63.99 84.90 1340 8212 0.1632 0.5194
MN20160318_Q02
C19